COMMUNIQUÉS West-GlobeNewswire

CURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery Production
01/05/2018
OXNARD, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced it received an investment of $500,000 from a strategic partner to [...]
OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories
01/05/2018
MIAMI, May 01, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ) today announced the appointment of Geoff Monk as General Manager with overall responsibility for BioReference Laboratories (BRL), an OPKO Health [...]
Scythian Biosciences Announces Extension of Letter of Intent
01/05/2018
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSX-V: SCYB ) (Frankfurt: 9SB ) (OTC – Nasdaq Intl:SCCYF) announced today that the Company has signed an agreement [...]
NanoVibronix to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and Reed Smith
01/05/2018
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV ), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today [...]
Ultragenyx to Host Conference Call for First Quarter 2018 Financial Results and Corporate Update
01/05/2018
NOVATO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced [...]
Profound Medical Further Strengthens Management Team with Appointment of Aaron Davidson as Chief Financial Officer and Senior Vice-President of Corporate Development
01/05/2018
TORONTO, May 01, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Body Count: Canadians with curable illnesses are dying every day without pharmacare, according to a new study from Canada’s nurses
01/05/2018
OTTAWA, May 01, 2018 (GLOBE NEWSWIRE) -- Canada’s nurses unveiled a new study today – the first of its kind in Canada – that reveals the number of people in Canada who die or fall ill because prescription medications [...]
Comptons les corps : Selon une nouvelle étude commandée par le personnel infirmier du Canada, des personnes atteintes de maladies curables meurent à chaque jour au pays en l’absence de régime universel d’assurance-médicaments
01/05/2018
OTTAWA, 01 mai 2018 (GLOBE NEWSWIRE) -- Le personnel infirmier du Canada a communiqué, aujourd’hui, une nouvelle étude – la première de ce genre au Canada – qui révèle le nombre de personnes au pays qui meurent ou [...]
Maple Leaf Begins Interior Construction on its Telkwa, British Columbia Facility
01/05/2018
CALGARY, Alberta, May 01, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (NEO: MGW ) (OTCQB:MGWFF) is pleased to announce that it has received a progress report from the Company [...]
COCRYSTAL PHARMA, INC., PRICES $8,000,000 COMMON STOCK OFFERING
01/05/2018
TUCKER, GA and BOTHELL, WA, May 01, 2018 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP) , (“Cocrystal” or the “Company”) a clinical stage biotechnology company focused on developing innovative antiviral [...]
Marrone Bio Innovations to Present at 3rd Annual RHK Capital Disruptive Growth & Healthcare Conference in New York on May 8th
01/05/2018
DAVIS, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]
Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018
01/05/2018
VANCOUVER, British Columbia, May 01, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“ APC ” or the “ Company ”) (TSXV:APC) (FSE:0E8) is pleased to provide an update of progress during the third [...]
Golden Leaf Holdings Opens New Chalice Farms Dispensary in Happy Valley, Oregon
01/05/2018
PORTLAND, Ore., May 01, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]
MPI - Publication of Merger Prospectus
01/05/2018
Medical Prognosis Institute A/S ("MPI") hereby publishes prospectus regarding the planned merger between MPI and Oncology Venture. The prospectus is available via MPI's website ( www.medical-prognosis.com ). For further [...]
Novo Nordisk A/S - Share repurchase programme
01/05/2018
Bagsværd, Denmark, 1 May 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
PositiveID’s ExcitePCR FireflyDX Prototype Successfully Detects E. Coli in Less Than 30 Minutes
01/05/2018
Detection at local processing or restaurant level is key to preventing outbreaks like romaine lettuce E. coli and egg-borne salmonella DELRAY BEACH, Fla., May 01, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“ [...]
MJ Biotech Inc. announces Online Radio Show
01/05/2018
CHEYENNE, Wyo., May 01, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) completed its fifth online radio show for the month of April, 2018. Last month the Corporate Executives [...]
Matinas BioPharma Selected to Present at the BioNJ Eighth Annual BioPartnering Conference
01/05/2018
BEDMINSTER, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative medicines using its proprietary lipid [...]
Medtronic Receives FDA Approval for Deep Brain Stimulation Therapy for Medically Refractory Epilepsy
01/05/2018
7-Year Data from the SANTE Trial Showed Median Seizure Frequency Reduction of 75 percent in Patients with Drug-Resistant Epilepsy with Partial-Onset Seizures Receiving DBS Therapy. DUBLIN - May 1, 2018 - Medtronic plc ( [...]

Pages